Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions

Taylor and Francis Group, Expert Opinion on Drug Safety, 4(21), p. 499-515, 2021

Journal article published in 2021 by Piotr Damiański, Grzegorz Kardas, Michał Panek, Piotr Kuna, Maciej Kupczyk

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by